首页> 外文期刊>Experimental Physiology >Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradioI regulation of renal pathology in renal wrap hypertension in rats
【24h】

Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradioI regulation of renal pathology in renal wrap hypertension in rats

机译:血管紧张素转换酶2和血管紧张素(1-7)在17β-雌激素调节大鼠肾包裹性高血压肾脏病理中的作用

获取原文
获取原文并翻译 | 示例

摘要

17beta-Oestradiol (E_2)-mediated inhibition of angiotensin-converting enzyme (ACE) protects the E_2-replete lddney from the progression of hypertensive renal disease. Angiotensin-converting enzyme 2 (ACE2), a homologue of ACE, counters the actions of ACE by catalysing the conversion of angiotensin II (Ang II) to angiotensin(1-7) [Ang(1-7)]. We investigated E_2 regulation of ACE2 in the renal wrap (RW) model of hypertension in rats. After 6 weeks on a high-sodium diet (4% NaCl), the activity of ACE2 was reduced in the renal cortex by 31 %, which was mirrored by similar decreases in ACE2 protein (30%) and mRNA expression (36%) in the ovariectomized RW rat (RW-OVX); E_2 replacement prevented these effects. The RW-OVX rats exhibited greater renal injury, including 1.7-fold more tubulointerstitial fibrosis and 1.6-fold more glomerulosclerosis than E_2-replete females (RW-Intact and RW-OVX+E_2). Angiotensin(1-7) infusion prevented these exacerbating effects of ovariectomy on renal pathology; no differences in indicators of renal injury were observed between RW-OVX-Ang(1-7) and RW-Intact rats. These renal protective effects of Ang(1-7) infusion were not attributable to increased ACE2 activity or to changes in heart rate or body weight, since these parameters were unchangedby Ang(1-7) infusion. Furthermore, Ang(1-7) infusion did not attenuate renal injury by reducing mean arterial pressure (MAP), since infusion of the peptide did not lower MAP but rather caused a slight increase during a 6 week chronic treatment for Ang(1-7). These results suggest that E2-mediated upregulation of renal ACE2 and the consequent increased Ang(1-7) production contribute to E_2-mediated protection from hypertensive renal disease. These findings have implications for E_2-deficient women with hypertensive renal disease and suggest that therapeutics targeted towards increasing ACE2 activity and Ang(1-7) levels will be renal protective.
机译:17β-雌二醇(E_2)介导的血管紧张素转换酶(ACE)抑制作用可保护E_2丰富的肾脏免受高血压肾病的发展。血管紧张素转换酶2(ACE2)是ACE的同源物,它通过催化血管紧张素II(Ang II)向血管紧张素(1-7)[Ang(1-7)]的转化来抵消ACE的作用。我们研究了大鼠高血压肾脏包裹(RW)模型中ACE_2的E_2调控。在高钠饮食(4%NaCl)下放置6周后,肾皮质中ACE2的活性降低了31%,这与ACE2蛋白(30%)和mRNA表达(36%)的相似下降相吻合。去卵巢的RW大鼠(RW-OVX); E_2替换可防止这些影响。 RW-OVX大鼠表现出更大的肾脏损伤,其中包括肾小管间质纤维化比E_2丰富的雌性(RW-Intact和RW-OVX + E_2)高1.7倍。血管紧张素(1-7)输注可防止卵巢切除术对肾脏病理的恶化作用。在RW-OVX-Ang(1-7)和RW-Intact大鼠之间未观察到肾损伤指标的差异。 Ang(1-7)输注的这些肾脏保护作用不是归因于ACE2活性增加或心率或体重的变化,因为Ang(1-7)输注未改变这些参数。此外,Ang(1-7)输注并不能通过降低平均动脉压(MAP)减轻肾脏损伤,因为肽的输注并不能降低MAP,而是在Ang(1-7)的6周慢性治疗期间引起了轻微的升高)。这些结果表明,E2介导的肾脏ACE2的上调以及随之而来的Ang(1-7)生成增加有助于E_2介导的针对高血压肾脏疾病的保护。这些发现对患有高血压肾病的E_2缺乏型妇女有影响,并表明针对增加ACE2活性和Ang(1-7)水平的疗法将具有肾脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号